It Is About Our Kras

It is about our Kras (Classical Karst)

Park Škocjanske jame, Slovenija

Frontline Treatment for KRAS Wild-Type mCRC

Targeted Oncology

KRAS in the clinic and conference

How do doctors treat lung cancer with KRAS mutations?

You and Lung Cancer

Dr. Cercek on the Need for Treatment Options in KRAS Mutated mCRC

Mitigating resistance in KRAS-driven cancers

KRAS-Mutant NSCLC

History of KRAS Testing in Advanced NSCLC

Targeted Oncology

Advances in the management of KRAS-mutant NSCLC

Challenges of KRAS-targeting for lung cancer therapy

Assessing the heterogeneity of KRAS-mutant pancreatic adenocarcinomas

What are the latest updates in non-G12C KRAS allele-specific inhibition?

Highlighting the benefits of KRAS testing in colorectal cancer

Treatment Options for KRAS-Mutant Unresectable mCRC

Targeted Oncology

Dr. David B. Solit on Inhibiting KRAS, HRAS, NRAS, and BRAF Genes

Targeted Oncology

Personalized treatment approaches for patients with KRAS-mutant pancreatic cancer

The potential of KRAS inhibitors for non-small-cell lung cancer

Kyung Chu on Treating Different Subtypes of the KRAS Mutation

Dr. Gius - Sirt2 Regulation of KRAS is an Early Event in Pancreas Carcinogenesis

HirshbergFoundation

Dr. Peeters on KRAS/NRAS Mutations in mCRC